NCT01719133View on ClinicalTrials.gov

Skin Prick Tests With AllerT in Subjects Allergic to Birch Pollen

PHASE1CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

February 29, 2008

Primary Completion Date

March 31, 2008

Study Completion Date

June 30, 2008

Conditions
Allergic Rhinitis
Interventions
DRUG

placebo

saline solution

DRUG

Histamine

positive control

DRUG

AllerT1

synthetic peptide T1

DRUG

AllerT2

synthetic peptide T2

DRUG

AllerT3

synthetic peptide T3

DRUG

AllerT4

synthetic peptide T4

DRUG

AllerT5

synthetic peptide T5

DRUG

mix of AllerT1-T2-T3

mix of peptides T1, T2 and T3

DRUG

mix of AllerT4-T5

mix T4-T5

Trial Locations (1)

Unknown

Centre Hospitalier Universitaire Vaudois, Lausanne

Sponsors

Lead Sponsor

Anergis
All Listed Sponsors
lead

Anergis

INDUSTRY

NCT01719133 - Skin Prick Tests With AllerT in Subjects Allergic to Birch Pollen | Biotech Hunter | Biotech Hunter